Study to improve brain function in newly diagnosed glioma patients
Part of Cancer clinical trials.
This Phase 3 study tests a treatment plan after surgery to improve brain function and quality of life in adults with newly diagnosed, specific types of brain tumors (gliomas). It may help you keep thinking clearly and living better while your tumor is treated with standard medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a newly diagnosed brain tumor called a glioma (WHO grade 2 or 3) proven by tissue testing
- Your tumor must have specific genetic changes: an IDH mutation and a co-deletion of 1p/19q
- You’re an adult (18 or older) and have enough recovery after brain surgery (healed biopsy/craniotomy site)
- Your scans and blood tests must be OK (and you must be able to have MRI), with enough life expectancy to complete study visits
- You must be able to do regular brain/cognitive and quality-of-life questionnaires and follow study instructions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1/2 trial tests a study treatment for children and young adults under 22 whose brain glioma has come back or isn’t responding to prior treatment. It’s designed to see whether the treatment is safe and effective for shrinking tumors in this situation.
This Phase 2 study tests a combination of chemotherapy and radiation after surgery for certain brain tumors that are “IDH wildtype.” It aims to control the tumor and improve outcomes for people with specific types of glioma or glioblastoma.
This Phase 1/2 trial tests two experimental treatments delivered through a thin catheter placed in the brain for people with newly diagnosed glioblastoma (GBM). The goal is to see whether the treatment can be given safely and whether it may shrink or control the tumor after standard chemotherapy and radiation.
This early-phase study uses special PET/MRI scans to look at how a newly diagnosed high-grade glioma is changing under standard treatment. The goal is to see whether these scans can better assess the disease, which may help guide future care.
This trial tests a new drug called ADI-PEG 20 combined with standard treatments (temozolomide and radiation) for children and young adults with newly diagnosed high-grade glioma. It aims to see if this combination is safe and effective.
This trial tests a combination of two drugs (D2C7-IT and 2141-V11) given directly into the brain after surgery for people with recurrent glioblastoma. The goal is to see if this treatment is safe and can help control the tumor.
Hear when a new Oligodendroglioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.